Who Owns NKGN?

NKGen Biotech Inc — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

Shares Outstanding

Institutional Holders

3

Total Inst. Value

$152K

% of Float Held

QoQ Holder Change

-9

Institutional data as of Q1 2025

New Positions

3

Closed Positions

0

Increased

0

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Diametric Capital, LPNew$93K518,134
2UNIVERSITY OF CHICAGONew$59K325,000
3FLOW TRADERS U.S. LLCNew$949,220

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
Diametric Capital, LPNew+518K$93K
UNIVERSITY OF CHICAGONew+325K$59K
FLOW TRADERS U.S. LLCNew+49K$9

Top Sellers

FundShares RemovedValue

Frequently Asked Questions

How many institutional investors hold NKGN?

As of Q1 2025, 3 institutional investors report holding NKGN (NKGen Biotech Inc) in their 13F filings.

Which hedge fund owns the most NKGN?

The largest institutional holder of NKGN is Diametric Capital, LP with $93K in shares.

Are institutions buying or selling NKGN?

This quarter, 3 institutions opened new positions in NKGN and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.